Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure
2010381 citationsRobert S. Gaston, J. Michael Cecka et al.Transplantationprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Bert L Kasiske
Since
Specialization
Citations
This map shows the geographic impact of Bert L Kasiske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert L Kasiske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert L Kasiske more than expected).
This network shows the impact of papers produced by Bert L Kasiske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert L Kasiske. The network helps show where Bert L Kasiske may publish in the future.
Co-authorship network of co-authors of Bert L Kasiske
This figure shows the co-authorship network connecting the top 25 collaborators of Bert L Kasiske.
A scholar is included among the top collaborators of Bert L Kasiske based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Bert L Kasiske. Bert L Kasiske is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Gaston, Robert S., J. Michael Cecka, Bert L Kasiske, et al.. (2010). Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure. Transplantation. 90(1). 68–74.381 indexed citations breakdown →
Kasiske, Bert L. (2000). Cardiovascular disease after renal transplantation.. PubMed. 20(2). 176–87.92 indexed citations
7.
Kasiske, Bert L, Jon J. Snyder, Arthur J. Matas, & Allan J. Collins. (2000). The impact of transplantation on survival with kidney failure.. PubMed. 135–43.26 indexed citations
8.
Massy, Ziad A., Carlos Guijarro, Michael P. O’Donnell, Bert L Kasiske, & W. F. Keane. (1997). Lipids, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, and progression of renal failure.. PubMed. 27. 39–56.4 indexed citations
9.
O’Donnell, Michael P., Bert L Kasiske, Young‐Ki Kim, D. Atluru, & W. F. Keane. (1993). The mevalonate pathway: importance in mesangial cell biology and glomerular disease.. PubMed. 19(3). 173–9.19 indexed citations
10.
Kasiske, Bert L, Michael P. O’Donnell, Paul G. Schmitz, & William F. Keane. (1991). The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease.. PubMed. 20. 109–25.9 indexed citations
11.
Awni, Walid M., K L Heim-Duthoy, & Bert L Kasiske. (1990). Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.. PubMed. 22(3). 1193–6.26 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.